Bone-related diseases (e.g., osteoporosis) represent a significant health challenge, prompting research for effective therapeutic agents, particularly from natural sources. The edible mushroom, Mycoleptodonoides aitchisonii has attracted interest due to its wide range of biological activities. Cytotoxicity assays revealed no significant toxicity of the M. aitchisonii water extract (MAWE) up to 50 μg/mL. MAWE significantly promoted dose-dependent osteoblast differentiation with ALP activity and mineralization increase by 109.17 % and 23 %, respectively, compared with the differentiation-only group. Moreover, MAWE significantly upregulated osteoblast-related gene expressions, including that of type I collagen (COL1A), osterix (Osx), and osteopontin (OPN). Furthermore, MAWE treatment significantly increased AMPK phosphorylation. This effect was further confirmed by demonstrating that the AMPK inhibitor compound C suppressed AMPK phosphorylation, and subsequent MAWE treatment restored it. In summary, these results demonstrate that MAWE possesses potent osteoblast differentiation-promoting efficacy, primarily through AMPK signaling pathway activation.

본 연구는 겐타마이신(GEN)을 돼지에 경구 투여한 다 음, 돼지 식용조직 내 GEN의 잔류농도를 조사하였으며, 돼지 식용조직에서 GEN의 적정 휴약기간을 설정하였다. 총 42마리의 건강한 돼지에게 체중 kg 당 1 . 1 mg (GEN- 1, n=20)과 2.2 mg (GEN-2, n=20)의 GEN을 하루에 한 번씩 3일 동안 연속적으로 경구투여하였다. 약물 투여 후, 1, 3, 5, 7, 14일째에 각각 돼지 4마리로부터 조직 시료를 채취하였다. 돼지 조직 내 GEN 잔류농도는 액체크로마토 그래피-질량분석법(LC-MS/MS)을 사용하여 측정하였다. 본 연구에, 확립한 LC-MS/MS의 상관계수는 0.9961에서 0.9996 사이였으며, 검출한계(LOD)와 정량한계(LOQ)는 각 각 0.003-0.008 mg/kg과 0.01-0.025 mg/kg이었다. 근육, 간, 신 장 및 지방 조직에서의 회수율은 각각 55.51-73.15%, 69.65- 78.21%, 66.56-83.29%, 96.76-107.74%였으며, 변이계수는 모두 11.16% 이하였다. GEN-1과 GEN-2 모두에서 근육, 간, 지방 시료 내 GEN 농도는 약제 투여 종료 후 1일째 에 LOQ 이하로 나타났다. 그러나 두 그룹 모두에서 신장 시료에서는 약제 투여 종료 후 7일째까지 LOQ 이상으로 GEN이 검출되었다. 유럽의약청(EMA)의 식용조직에 대한 휴약기간 설정 지침에 따라서, GEN-1과 GEN-2의 돼지 조 직 내 휴약기간은 각각 2일 및 9일로 설정되었다. 이상의 결과로부터, 본 연구에서 확립된 분석법은 돼지 조직 내 GEN 검출에 적합하며, 설정된 GEN의 휴약기간은 돼지 식용조직 제품의 안전성 확보에 기여할 것으로 판단된다.

This study was conducted to reset the withdrawal time (WT) for amoxicillin (AMX) in pigs as a part of positive list system (PLS) program introduction. Forty-two healthy pigs were orally administered with AMX at doses of 10 mg/kg body weight (BW) (AMX-1, n=20) and 20 mg/kg BW (AMX-2, n=20), twice daily for 5 days, respectively. After the treatment, tissue samples were collected from four pigs at 1, 3, 5, 7 and 14 days post-administration, respectively. Based on a previously established analysis method, residual AMX concentrations in pig tissues were determined using LC-MS/MS. In both AMX-1 and AMX-2 groups, AMX levels in all tissues except fat was below the limit of quantification (LOQ) at one day after the final administration. According to the European Medicines Agency’s guideline on determination of withdrawal periods, the withdrawal periods for AMX-1 and AMX-2 in fat tissue were established as 0 and 2 days, respectively. In conclusion, the estimated WT of AMX in edible tissues of pigs is shorter than the current WT recommendation of 5 days for AMX.

This study evaluated the bactericidal efficacy of a disinfectant containing chlorine dioxide as its main ingredient against Paenibacillus larvae (P. larvae) that is the causative agent of American foulbrood. A bactericidal efficacy test by broth dilution method was used to determine the lowest effective dilution of the disinfectant following exposure to P. larvae for 30 min at 4°C. The disinfectant and test bacterium were diluted with low and high organic matter (OM) suspension according to treatment condition. On low and high OM conditions, the bactericidal activity of the disinfectant against P. larvae was 2.5 and 1.25 fold dilution, respectively. The recommended dilution time of the disinfectant in low and high OM was 2.0 and 1.0 fold dilution, respectively. As the disinfectant possesses bactericidal efficacy against P. larvae, the disinfectant can be used to prevent American foulbrood in larvae of honeybees.

Amitriptyline hydrochloride (AMT), a tricyclic antidepressant, is known to exhibit antimicrobial effects against a wide range of bacterial species. This study aims to evaluate the effect of AMT on Brucella (B.) abortus infection in RAW 264.7 cells and ICR mice, which has not yet been clearly characterized. The results showed that all tested concentrations of AMT had no direct bactericidal effect on B. abortus survival at any incubation time point. Interestingly, RAW 264.7 cells pre-treated with a non-toxic high concentration of AMT before B. abortus infection showed a significant reduction in the phagocytosis of B. abortus at 20 min post-infection, compared to untreated cells. However, AMT treatment did not affect the intracellular replication of B. abortus compared to the control cells. Based on the reduced bacterial uptake observed in-vitro, an in-vivo experiment was conducted to assess whether daily oral administration of AMT at a dose of 20 mg/kg could inhibit B. abortus growth in ICR mice. The results showed that AMT treatment slightly increased both organ weights and bacterial loads, suggesting possible systemic effects of prolonged AMT exposure. In summary, these preliminary results provide initial insight into the potential effects of AMT on B. abortus infection both in-vitro and in-vivo. Therefore, further study should focus on dose optimization in-vivo and exploration of the underlying cellular mechanisms involved in AMT-mediated inhibition of phagocytosis during Brucella infection.

The role of the gut microbiota in colorectal cancer (CRC) development has garnered attention, highlighting probiotics as potential adjuncts in CRC prevention and treatment. In recent years, probiotics and their derivatives have demonstrated mechanisms that may contribute to anticancer properties. This study investigates the cytotoxic effects of Bifidobacterium bifidum KCTC 3357, Lacticaseibacillus rhamnosus KCTC 5033, Limosilactobacillus reuteri VA 103, Bacillus galactosidilyticus VA 107, and Lactococcus taiwanensis VE101 on CT-26 mouse colon carcinoma cells using live cells, heat-killed cells (paraprobiotics), and cell-free supernatants (CFS, postbiotics) through an MTT assay. The results indicate that live bacterial strains, such as KCTC 3357, VA 103, and VA 107, promoted CT-26 cell viability, while heat-killed cells and CFS exhibited dose-dependent cytotoxicity. Inactivated forms of KCTC 3357 and VE 101, as well as CFS at 10 mg/mL concentration of KCTC 5033, VA 103, and VE 101, showed the strongest antiproliferative effects. These findings suggest that non-viable probiotic derivatives, such as paraprobiotics and postbiotics, offer promising therapeutic potential for CRC, providing a safer and more stable alternative to live probiotics. However, further research is required to explore their mechanisms of action, in vivo efficacy, and potential clinical applications.

Probiotics have been evaluated as therapeutic agents for cancer treatment in an increasing number of studies. This study investigated the inhibitory and cytotoxic effects of specific Lactobacillus strains on a human colorectal adenocarcinoma cell line (HT-29). The strains assessed were Limosilactobacillus (L.) reuteri VA 102, Ligilactobacillus (L.) animalis VA 105, and Limosilactobacillus (L.) reuteri KCTC 3594 (ATCC 23272). The viability of HT-29 cells was evaluated using the MTT assay. The findings revealed that cell-free supernatants (CFS) exhibited significant anticancer effects. Heat-inactivated L. reuteri VA 105 and L. reuteri KCTC 3594 induced a pronounced reduction in cell viability. Furthermore, live cultures of L. reuteri VA 105 and L. reuteri VA 102 also showed reduced cell viability compared to the control group. These results suggest that CFS and heat-inactivated cells may be more suitable for therapeutic applications than live bacteria owing to their improved safety profiles and reduced potential for adverse effects. Our findings also emphasize the potential anticancer benefits of these LAB strains.

This study evaluated the efficacy of a wild boar repellent (Repellent A) consisting of tannins and plant oils (castor oil, garlic oil, and cinnamon oil). Sixty farmed wild boars (4-8 months old) were divided into three groups: the normal control group (NC, n=20), the experimental group (EP, n=20), and the comparative experimental group (C-EP, n=20), which used Repellent B consisting of guaiacol, eugenol, menthol, thymol, and indole. EP and C-EP were equipped with four repellents per feeder, while no repellents were installed in the NC feeder. The feed intake and the number of feeding approaches were measured for one week in all groups. The number of approach of wild boars in feeders was monitored daily using a CCTV camera. The daily feed intake per farmed wild boar in EP and C-EP was significantly decreased compared to NC (p<0.05), and EP was significantly decreased compared to C-EP (p<0.05). In the average number of daily approaches, EP and C-EP were significantly decreased compared to NC (p<0.05), and EP was significantly decreased compared to C-EP (p<0.05). In conclusion, Product A has been confirmed to have excellent repellent effects on wild boars, and it could be used to prevent wild boars from approaching pig farms.

Schlumbergera truncata absorbs CO2 through its mature phylloclades during the night, and can use a substantial amount of CO2 without requiring ventilation. This study investigated the growth and photosynthetic responses of S. truncata ‘Red Candle’ at two CO2 levels—ambient (≈ 400 μmol･mol-1) and elevated (≈ 1000 μmol･mol-1). At 0–8 weeks after treatment (WAT), width and length of mature phylloclade and length of immature phylloclade did not differ significantly among the CO2 treatments. At 4–8 WAT, number of branches and phylloclades were significantly greater in plants grown under ambient CO2 than those under elevated CO2. Net CO2 uptake was highest in mature phylloclades of plants grown under ambient and elevated CO2 regimes at night, at 2.51 and 1.30 μmol·CO2·m-2·s-1, respectively. However, no statistically significant variation was observed at 6 WAT, and stomatal conductance was significantly affected only by CO2 uptake time at 6 and 8 WAT. Water-use efficiency of mature and immature phylloclades at night increased with increase in CO2 levels (r = 0.7462 and 0.9312, respectively). At 123 days after treatment, plants grown under elevated CO2 had 82.7 floral buds, compared to 72.1 buds in those under ambient CO2. However, this difference was not statistically significant. Moreover, S. truncata grown under elevated CO2 exhibited decreased growth and photosynthesis, whereas the number of floral buds did not exhibit any significant differences among the treatments.

본 논문은 모바일 폰 사진을 활용하여 도시 공간에서 전력선과 건물 사이의 거리를 편리하게 모델링하고 측정하는 방법에 중점을 두고 있으며, 이에 대한 정확성을 평가하였다. 모바일 장 치용 2뷰 지오메트리를 사용한 전력선과 건물의 3D 재구성 방법을 설계하여 어디에서나 즉시 측정할 수 있도록 하였다. 특징점을 사용하여 전력선과 건물 사이의 거리를 계산하고 건물 정 보를 활용하여 게임 가상 공간에 전력선과 전주를 배치할 수 있다. 본 논문에서는 대전시 내 10개의 위치에서 실험을 실시하고, 상업용 시스템과 LiDAR가 있는 경우와 없는 경우를 포함 한 이전 방법과의 성능을 평가하였다. 우리의 방법을 스마트폰에 구현했기 때문에 장점은 휴 대성과 저렴함이다.

From 2020, Korean Animal and Plant Quarantine Agency has reset the withdrawal time (WT) for veterinary drugs typically used in livestock in preparation for the introduction of positive list system (PLS) program in 2024. This study was conducted to reset the MRL for tiamulin (TML) in broiler chickens as a part of PLS program introduction. Forty-eight healthy Ross broiler chickens were orally administered with TML at the concentration of 25 g/L (TML-1, n=24) and 50 g/L (TML-2, n=24) for 5 days through drinking water, respectively. After the drug treatment, tissue samples were collected from six broiler chickens at 1, 2, 3 and 5 days, respectively. According to the previously established analysis method, residual TML concentrations in poultry tissues were determined using LC-MS/MS. In TML-1, TML in all tissues was detected less than LOQ at 2 days after drug treatment. In TML-2, TML in liver and kidney was detected more than LOQ at 2 days after treatment. According to the European Medicines Agency’s guideline on determination of withdrawal periods, withdrawal periods of TML-1 and TML-2 in poultry tissues were established to 0 and 2 days, respectively. In conclusion, the estimated WT of TML in poultry tissues is shorter than the current WT recommendation of 5 days for TML in broiler chickens.